Parents' perceived obstacles to pediatric clinical trial participation: Findings from the clinical trials transformation initiative-Reference-Cited by-同舟云学术

Parents' perceived obstacles to pediatric clinical trial participation: Findings from the clinical trials transformation initiative

Published:2018-03 Issue: Volume:9 Page:33-39
ISSN:2451-8654
Container-title:Contemporary Clinical Trials Communications
language:en
Short-container-title:Contemporary Clinical Trials Communications

Author:

Greenberg Rachel G.,Gamel Breck,Bloom Diane,Bradley John,Jafri Hasan S.,Hinton Denise,Nambiar Sumathi,Wheeler Chris^ORCID,Tiernan Rosemary,Smith P. Brian,Roberts Jamie^ORCID,Benjamin Daniel K.

Funder

National Institutes of Health (NIH)

FDA

NIH

National Institute for Child Health and Human Development (NICHD)

NICHD

National Institute of Allergy and Infectious Diseases

Extended Care Health Option Program

National Center for Advancing Translational Sciences

Cempra Pharmaceuticals

Food and Drug Administration

CTTI's member organizations

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference29 articles.

1. Best Pharmaceuticals for Children Act (BPCA), Public Law,2002

2. U.S. Food and Drug Administration Amendments Act, Public Law,2007

3. U.S. Food and Drug Administration Modernization Act of 1997, Public Law,1997

4. Pediatric Research Equity Act (PREA), Public Law,2007

5. U.S. Food and Drug Administration Safety and Innovation Act, Public Law,2012

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Motivations for and against Participation in Neonatal Research: Insights from Interviews of Diverse Parents Approached for Neonatal Research in the United States;The Journal of Pediatrics;2024-12

2. Development of the Better Research Interactions for Every Family (BRIEF) intervention to support recruitment for neonatal clinical trials: an intervention mapping guided approach;Trials;2024-09-12

3. Pediatric drug delivery challenges: Enhancing compliance through age-appropriate formulations and safety measures;Journal of Drug Delivery Science and Technology;2024-06

4. Unlocking the Potential: A Systematic Review of Master Protocol in Pediatrics;Therapeutic Innovation & Regulatory Science;2024-04-23

5. Sources of pharmacokinetic and pharmacodynamic variability and clinical pharmacology studies of antiseizure medications in the pediatric population;Clinical and Translational Science;2024-04